Canadian HTA Consults On Improvements To Drug Review Processes
Proposals on reforming health technology assessment processes would “improve the accessibility and appropriate use of publicly funded drugs,” says Canadian health technology appraisal body, CADTH.
You may also be interested in...
Immunotherapies for esophageal cancer from BMS and MSD are among the medicines that Scotland’s health technology appraisal body has recommended for use on the National Health system.
Indication-based pricing and tackling complications caused by competition law could help the UK catch up with other countries when it comes to market access for combination therapies.
Orchard Therapeutics says it is confident in the success of its gene therapy for MLD, which has secured the highest possible benefit rating from the German authorities.